Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Arch Biopartners (TSE:ARCH)
TSXV:ARCH
Arch Biopartners (ARCH) Stock Price & Analysis
17 Followers
ARCH Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.97 - C$2.56
Previous CloseC$1.59
Volume43.50K
Average Volume (3M)20.44K
Market Cap
C$99.78M
Enterprise ValueC$104.52M
Total Cash (Recent Filing)C$302.63K
Total Debt (Recent Filing)C$5.04M
Price to Earnings (P/E)―
Beta1.10
Next Earnings
Aug 27, 2024EPS Estimate
-C$0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding62,755,633
10 Day Avg. Volume36,132
30 Day Avg. Volume20,439
Standard Deviation0.19
R-Squared0.05
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)-18.12
Price to Sales (P/S)-95.88
Price to Cash Flow (P/CF)-47.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Arch Biopartners News
Options Prices
Currently, No data available
---
Ownership Overview
44.53% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
55.47% Public Companies and
Individual Investors
ARCH FAQ
What was Arch Biopartners’s price range in the past 12 months?
Arch Biopartners lowest stock price was C$0.97 and its highest was C$2.56 in the past 12 months.
What is Arch Biopartners’s market cap?
Currently, no data Available
When is Arch Biopartners’s upcoming earnings report date?
Arch Biopartners’s upcoming earnings report date is Aug 27, 2024 which is in 31 days.
How were Arch Biopartners’s earnings last quarter?
Arch Biopartners released its earnings results on May 30, 2024. The company reported -C$0.018 earnings per share for the quarter, beating the consensus estimate of -C$0.02 by C$0.002.
Is Arch Biopartners overvalued?
According to Wall Street analysts Arch Biopartners’s price is currently Overvalued.
Does Arch Biopartners pay dividends?
Arch Biopartners does not currently pay dividends.
What is Arch Biopartners’s EPS estimate?
Arch Biopartners’s EPS estimate is -C$0.02.
How many shares outstanding does Arch Biopartners have?
Arch Biopartners has 62,755,634 shares outstanding.
What happened to Arch Biopartners’s price movement after its last earnings report?
Arch Biopartners reported an EPS of -C$0.018 in its last earnings report, beating expectations of -C$0.02. Following the earnings report the stock price went up 0.595%.
Which hedge fund is a major shareholder of Arch Biopartners?
Currently, no hedge funds are holding shares in TSE:ARCH
---
Arch Biopartners Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-24.64%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-51.55%
Trailing 12-Months
Company Description
Arch Biopartners
Arch Biopartners Inc is a clinical stage company developing technologies with the potential to make medical or commercial impacts. The company is developing a drug platform Metablok to produce drug candidates to inhibit organ inflammation caused via the DPEP-1 pathway. Its under development portfolio is AB569, a potential new treatment for antibiotic resistant bacterial infections in the lungs or wounds; and, Borg peptide coatings that increase corrosion resistance and decrease bacterial biofilm on various medical grade metals and plastics.
---
ARCH Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---